These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors.
    Author: Gervais DA, Goldberg SN, Brown DB, Soulen MC, Millward SF, Rajan DK.
    Journal: J Vasc Interv Radiol; 2009 Jul; 20(7 Suppl):S342-7. PubMed ID: 19560023.
    Abstract:
    Focal tumor ablation--whether applied percutanously, laparoscopically, or by means of open surgery--is an effective therapy for selected liver tumors. The choice of liver ablation as well as the choice between percutaneous and surgical approaches is dependent on tumor factors, patient factors, and other viable treatment options. Currently, the largest cumulative reported experience is with radiofrequency (RF) ablation of hepatocellular carcinoma and colorectal metastases. This document is a position statement of the Interventional Oncology Task Force and the Standards Division of the Society of Interventional Radiology regarding the use of percutaneous RF ablation for the treatment of liver tumors.
    [Abstract] [Full Text] [Related] [New Search]